Literature DB >> 16805790

A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter.

Ulrich J H Sachs1, Ines Socher, Christian G Braeunlich, Hartmut Kroll, Gregor Bein, Sentot Santoso.   

Abstract

The neonatal Fc receptor, FcRn, plays a central role in immunoglobulin G (IgG) transport across placental barriers. Genetic variations of FcRn-dependent transport across the placenta may influence antibody-mediated pathologies of the fetus and the newborn. Sequencing analysis of 20 unrelated individuals demonstrated no missense mutation within the five exons of the FcRn gene. However, a variable number of tandem repeats (VNTR) region within the FcRn promoter was observed, consisting of five different alleles (VNTR1-VNTR5). Alleles with two (VNTR2) and three (VNTR3) repeats were found to be most common in Caucasians (7.5 and 92.0%, respectively). Real-time polymerase chain reaction revealed that monocytes from VNTR3 homozygous individuals express 1.66-fold more FcRn transcript than do monocytes from VNTR2/VNTR3 heterozygous individuals (P = 0.002). In reporter plasmid assays, the VNTR3 allele supported the transcription of a reporter gene twice as effectively as did the VNTR2 allele (P = 0.003). Finally, under acidic conditions, monocytes from VNTR3 homozygous individuals showed an increased binding to polyvalent human IgG when compared with monocytes from VNTR2/VNTR3 heterozygous individuals (P = 0.021). These data indicate that a VNTR promoter polymorphism influences the expression of the FcRn receptor, leading to different IgG-binding capacities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805790      PMCID: PMC1782336          DOI: 10.1111/j.1365-2567.2006.02408.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn.

Authors:  Raimund J Ober; Cruz Martinez; Carlos Vaccaro; Jinchun Zhou; E Sally Ward
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Co-localization of the neonatal Fc gamma receptor and IgG in human placental term syncytiotrophoblasts.

Authors:  E K Kristoffersen; R Matre
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

3.  Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.

Authors:  B Zupańska; E Brojer; Y Richards; B Lenkiewicz; H Seyfried; P Howell
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

4.  Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.

Authors:  J L Leach; D D Sedmak; J M Osborne; B Rahill; M D Lairmore; C L Anderson
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

5.  A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes.

Authors:  R S Blumberg; T Koss; C M Story; D Barisani; J Polischuk; A Lipin; L Pablo; R Green; N E Simister
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Red cell antibodies in pregnancy: there is no 'critical titre'.

Authors:  B A van Dijk; M C Dooren; M A Overbeeke
Journal:  Transfus Med       Date:  1995-09       Impact factor: 2.019

7.  An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta.

Authors:  N E Simister; C M Story; H L Chen; J S Hunt
Journal:  Eur J Immunol       Date:  1996-07       Impact factor: 5.532

8.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants.

Authors:  M Raghavan; V R Bonagura; S L Morrison; P J Bjorkman
Journal:  Biochemistry       Date:  1995-11-14       Impact factor: 3.162

9.  Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice.

Authors:  J Borvak; J Richardson; C Medesan; F Antohe; C Radu; M Simionescu; V Ghetie; E S Ward
Journal:  Int Immunol       Date:  1998-09       Impact factor: 4.823

10.  The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.

Authors:  L M Williamson; G Hackett; J Rennie; C R Palmer; C Maciver; R Hadfield; D Hughes; S Jobson; W H Ouwehand
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

View more
  31 in total

Review 1.  Bevacizumab.

Authors:  Filis Kazazi-Hyseni; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2010-08-05

Review 2.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

Review 3.  How the controller is controlled - neonatal Fc receptor expression and immunoglobulin G homeostasis.

Authors:  Shuo-Wang Qiao; Wayne I Lencer; Richard S Blumberg
Journal:  Immunology       Date:  2006-11-28       Impact factor: 7.397

Review 4.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

5.  Immunoglobulins: current understanding and future directions.

Authors:  S Jolles; S C Jordan; J S Orange; I N van Schaik
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

6.  Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients.

Authors:  J Litzman
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

7.  7th International Immunoglobulin Conference: Mechanisms of action.

Authors:  M Basta; D R Branch
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

8.  Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Authors:  E Oksenhendler
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

9.  A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease.

Authors:  Thomas Billiet; Erwin Dreesen; Isabelle Cleynen; Willem-Jan Wollants; Marc Ferrante; Gert Van Assche; Ann Gils; Severine Vermeire
Journal:  Am J Gastroenterol       Date:  2016-08-02       Impact factor: 10.864

10.  Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Authors:  V Gouilleux-Gruart; H Chapel; S Chevret; M Lucas; M Malphettes; C Fieschi; S Patel; D Boutboul; M-N Marson; L Gérard; M Lee; H Watier; E Oksenhendler
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.